- United States
- /
- Insurance
- /
- NYSE:HCI
3 Growth Companies With High Insider Ownership Seeing Up To 63% Revenue Growth
As the U.S. stock market navigates uncertainties, such as potential government shutdowns and fluctuating indices, investors are increasingly focused on companies that demonstrate resilience and growth potential. In this context, growth companies with high insider ownership can be particularly appealing due to their potential alignment of interests between management and shareholders, often leading to robust revenue growth even amidst broader market challenges.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Upstart Holdings (UPST) | 12.6% | 93.2% |
| Niu Technologies (NIU) | 37.2% | 92.8% |
| IREN (IREN) | 11.2% | 67.4% |
| Hippo Holdings (HIPO) | 14.0% | 41.2% |
| Hesai Group (HSAI) | 15.5% | 41.5% |
| FTC Solar (FTCI) | 23.1% | 63% |
| Credo Technology Group Holding (CRDO) | 11.3% | 33% |
| Celsius Holdings (CELH) | 10.8% | 32.2% |
| Atour Lifestyle Holdings (ATAT) | 21.8% | 23.5% |
| Astera Labs (ALAB) | 12.1% | 36.8% |
Underneath we present a selection of stocks filtered out by our screen.
Celcuity (CELC)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Celcuity Inc. is a clinical-stage biotechnology company that develops targeted therapies for treating various solid tumors in the United States, with a market cap of $2.15 billion.
Operations: Celcuity Inc. does not currently have any reported revenue segments.
Insider Ownership: 10.7%
Revenue Growth Forecast: 63.3% p.a.
Celcuity is poised for significant growth, with expected revenue increases of 63.3% annually, outpacing the broader U.S. market. Despite a volatile share price and current net losses, the company’s financial flexibility has been bolstered by an amended $500 million credit facility. Recent FDA acceptance of its New Drug Application for gedatolisib highlights promising clinical progress in breast cancer treatment, potentially enhancing Celcuity's market position and supporting future profitability within three years.
- Delve into the full analysis future growth report here for a deeper understanding of Celcuity.
- The analysis detailed in our Celcuity valuation report hints at an inflated share price compared to its estimated value.
Liquidia (LQDA)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Liquidia Corporation is a biopharmaceutical company focused on developing, manufacturing, and commercializing products for unmet patient needs in the United States, with a market cap of $1.88 billion.
Operations: The company generates revenue primarily from its Pharmaceuticals segment, which amounts to $19.32 million.
Insider Ownership: 10%
Revenue Growth Forecast: 43.8% p.a.
Liquidia's revenue is forecast to grow at 43.8% annually, significantly outpacing the U.S. market average of 9.7%. Despite current net losses, with a recent quarterly net loss of US$41.58 million, the company is expected to become profitable within three years. Insider activity shows more shares bought than sold recently, indicating confidence in its growth trajectory. Liquidia trades at a substantial discount to its estimated fair value, suggesting potential upside as it progresses towards profitability.
- Unlock comprehensive insights into our analysis of Liquidia stock in this growth report.
- Our comprehensive valuation report raises the possibility that Liquidia is priced higher than what may be justified by its financials.
HCI Group (HCI)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: HCI Group, Inc., along with its subsidiaries, operates in the property and casualty insurance, insurance management, reinsurance, real estate, and information technology sectors in the United States with a market cap of approximately $2.43 billion.
Operations: The company's revenue is primarily derived from its insurance operations at $726.94 million, followed by reciprocal exchange operations contributing $49.26 million, and real estate generating $11.12 million.
Insider Ownership: 14.3%
Revenue Growth Forecast: 11.4% p.a.
HCI Group exhibits strong growth potential with earnings forecasted to rise significantly at 25.5% annually, surpassing the U.S. market average. Recent results show robust performance, with Q2 revenue increasing to US$221.92 million and net income reaching US$66.16 million. Despite past shareholder dilution, the stock trades at a significant discount to its estimated fair value, indicating possible upside as it continues its growth trajectory without substantial insider trading activity in recent months.
- Click here and access our complete growth analysis report to understand the dynamics of HCI Group.
- According our valuation report, there's an indication that HCI Group's share price might be on the cheaper side.
Summing It All Up
- Click here to access our complete index of 201 Fast Growing US Companies With High Insider Ownership.
- Ready To Venture Into Other Investment Styles? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if HCI Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:HCI
HCI Group
Engages in the property and casualty insurance business in the United States.
Outstanding track record with flawless balance sheet and pays a dividend.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives

A Debt-Free PGM Producer Trading at 2x EBITDA With a 10% Dividend Yield Nobody Is Talking About

A Compelling Compounder at a Retailer's Multiple

Zijin Mining is a scaled, globally diversified mining platform
Popular Narratives

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Investment Analysis (May 2026)
